BriaCell Therapeutics (BCTX) Metrics: History & Chart

BriaCell Therapeutics Corp.(BCTX)

Biotechnology · West Vancouver, BC

$4.03-0.15 (-3.59%)

Delayed quote: Oct 6, 2026, 1:58 PM EDT

About BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer. The firm's leading experimental drug, Bria-IMT, is currently undergoing Phase I/IIa clinical investigation. This crucial study evaluates its effectiveness when utilized in conjunction with immune checkpoint inhibitors for treating breast cancer. Beyond its flagship program, BriaCell has forged a collaborative research and development partnership with the National Cancer Institute (NCI). This alliance is dedicated to progressing Bria-OTS, a personalized immunotherapy designed for advanced breast cancer patients, and BriaDx, a proprietary diagnostic assay. The company's main offices are situated in West Vancouver, Canada.

West Vancouver, BC

16 employees

www.briacell.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: William V. Williams

View full financials

Third-Party DCF Estimate (FMP)	$4.13
Price Gap vs Third-Party Estimate	-1.11%

7D Total Return	+0.48%
30D Total Return	+17.09%
YTD Total Return	-41.21%
1Y Total Return	-68.04%
3Y Total Return	-99.53%
5Y Total Return	-99.63%
10Y Total Return	-99.95%
15Y Total Return	-99.98%
20Y Total Return	N/A

2026	-41.21%
2025	-91.61%
2024	-90.34%
2023	+33.87%
2022	-47.22%
2021	+98.56%
2020

CAGR TTM	-67.87%
CAGR 3Y	-83.22%
CAGR 5Y	-67.32%
CAGR 10Y	-52.81%
CAGR 15Y	-43.19%
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

BCTX Valuation Metrics

BCTX Stock Price Metrics

BCTX Dividend Metrics

BCTX Growth Rate Metrics

BCTX Discounted Cash Flow Metrics

BCTX Returns By Period

BCTX Yearly Returns

BCTX Average Annual Returns By Period (CAGR)

BCTX Revenue Metrics

BCTX PE Ratio Metrics

BCTX PS Ratio Metrics

BCTX PB Ratio Metrics

BCTX Price to Free Cash Flow Ratio Metrics

BCTX Debt to Equity Ratio Metrics

BCTX PEG Ratio Metrics

BCTX FCF Yield

BCTX Earnings Yield

BCTX EBITDA Yield

BCTX OCF Yield

BCTX EV/EBIT Ratio Metrics

BCTX EV/EBITDA Ratio Metrics

BCTX EV/Assets Ratio Metrics

BCTX EV/Sales Ratio Metrics

BCTX Current Ratio Metrics

BCTX Quick Ratio Metrics

BCTX ROIC Metrics

BCTX Return on Assets Metrics

BCTX Return on Equity Metrics

BCTX Net Profit Margin Metrics

BCTX Gross Profit Margin Metrics

BCTX Tax Rate Metrics

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	1.26
PB Ratio Avg TTM	0.86
PB Ratio Avg 3Y	5.80
Current VS TTM Avg	+47.22%
Current VS 3Y Avg	-78.27%
Current VS 5Y Avg	-90.11%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.87
Ev/Assets Ratio Avg TTM	0.55
Ev/Assets Ratio Avg 3Y	10.54
Current VS TTM Avg	+59.55%
Current VS 3Y Avg	-91.75%
Current VS 5Y Avg	-93.62%

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Current Ratio	7.07
Current Ratio Avg TTM	5.80
Current Ratio Avg 3Y	6.94
Current VS TTM Avg	+21.86%
Current VS 3Y Avg	+1.91%
Current VS 5Y Avg	-68.85%

Quick Ratio	7.07
Quick Ratio Avg TTM	5.80
Quick Ratio Avg 3Y	6.94
Current VS TTM Avg	+21.86%
Current VS 3Y Avg	+1.91%
Current VS 5Y Avg	-68.85%

ROIC	(164.58%)
ROIC Avg 3Y	(268.44%)
ROIC Avg 5Y	(98.10%)
Current VS 3Y Avg	+38.69%
Current VS 5Y Avg	-67.76%
Current VS 10Y Avg	+18.61%

ROA	(136.91%)
ROA Avg TTM	(41.88%)
ROA Avg 3Y	(31.60%)
Current VS TTM Avg	-226.90%
Current VS 3Y Avg	-333.24%
Current VS 5Y Avg	-657.24%

ROE	(154.06%)
ROE Avg TTM	(198.59%)
ROE Avg 3Y	(272.18%)
Current VS TTM Avg	+22.42%
Current VS 3Y Avg	+43.40%
Current VS 5Y Avg	+19.23%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A